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      Allium ascalonicum is a part of the diet of many populations of the world due to their long-held beliefs. 
A. ascalonicum extracts have been reported have antibacterial properties and prevent cancer 
cell proliferation. This study was conducted for the purpse of evaluating the anticancer and antibacterial 
activity of a flavonoid fraction isolated from A. ascalonicum bulbs.  The HeLa and HUVEC cells were used 
as target cell line and some gram negative and positive bacteria were also targeted for antimicrobial activity. 
The A. ascalonicum plant was collected from the Zagros Mountains in the north of Dezful city- Iran, in 
September 2016 and confirmed by School of Pharmacy, Ahvaz Jundishapur University of Medical 
Sciences, Ahvaz, Iran. The water extract of bulbs of this plant was extracted and the flavonoid fraction was 
isolated from aquous extract by ethyl acetate. The antibacterial and anticancer effects of isolated falavonoid 
were determined using MIC and MTT respectively. The best antibacterial effect of falvonoid extracted from 
A.ascalonicum was found against C. diphtheria. Furthermore, gentamicin resistant P.aeruginosa was the 
most resistant pathogenic bacterium. The MTT method showed that this fraction had a concentration-
dependent anti-proliferative activity on HeLa cell lines and there was no cytotoxic effect against 
HUVEC cells.      The inhibitory concentration 50% (IC50) values of the A. ascalonicum extract for Hela 
cell was 3 mg/mL but the treatment of HUVECs with the A. ascalonicum showed no considerable effect. 
The flavonoid fraction of A.ascalonicum bulbs had remarkable antibacterial and anticancer properties. 
Therefore, it could be used as an antibacterial and anticancer agent for control of cancers and infectious 
diseases. 
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INTRODUCTION 
       Allium plants are members of the Liliaceae 
family and consist of more than seven hundred 
species [1]. However, only three species, 
including Allium ascalonicum (Shallot), Allium 
sativum (garlic) and Allium cepa (onion) are well-
known remedies in the prevention and treatment 
of diseases [2,3]. Traditional medicine has a very 
honorable past in Iran and medicinal plants play a 
key role in          this       country.      Nowadays,  
traditional herbal medicine is still widely used in 
all cities and villages of Iran and there are “Attari 
stores”, which sell herbals drugs [4-6]. Infectious 
diseases and cancers are the most common causes 
of death in many populations of the world and 
mankind have been grappling with this problem 
from the beginning. The adverse side effects and 




resistance of synthetic antimicrobial and 
anticancer drugs have increased the necessity for 
the discovery of novel natural compounds. 
Recently, the use of herbal medicines has been 
considered for treatment of infectious diseases 
and cancers due to their fewer side effects, 
compression to chemical medicines [7-9]. 
A.ascalonicum is abundant in the Razavi-
Khorasan and Lorestan provinces of Iran [1-7]. 
This herbal medicine has many potential benefits 
including antifungal and antibacterial properties, 
antioxidant activity, beneficial hematological 
effects and has been used for the treatment of 
rheumatism, kidney stones and decrease blood 
pressure [10,11]. A. ascalonicum plant contains 
saponin, sapogenine, ajoene and flavonoid 
extracts. Several studies have been conducted on 
the antibacterial and anticancer properties of total 
extract of A. ascalonicum and proved these 
activities against a variety of pathogenic bacteria 
and human cancer cell lines [12,13]. Despite the 
vast knowledge of herbal medicines in Iran, a few 
attempts have been performed to evaluate the 
antibacterial and anticancer effects of different 
fractions of shallot in this country. The aims of 
this study were the investigation of anticancer 
and antibacterial activity of flavonoid fraction of 
this plant against human cancer cell lines and 
some pathogenic bacteria using MTT method and 
MIC.  
 
MATERIALS AND METHODS 
Bacterial strains and Human cell lines 
   The current survey was a descriptive cross-
sectional study. Bacterial strains 
including vancomycin resistant Staphylococcus 
aureus (PTCC: 29213), methicillin resistant 
Staphylococcus aureus (PTCC 33591), 
vancomycin resistant Enterococcus faecalis 
(PTCC 51299), gentamicin resistant 
Pseudomonas aeruginosa (clinical), tobramycin 
resistant Escherichia coli (clinical), Bacillus 
cereus (PTCC 11778), Corynebacterium 
diphtheriae, Escherichia coli (PTCC 25922) 
Streptococcus pyogenes (PTCC 12386), and 
Klebsiella pneumoniae (PTCC 700603), as well 
as human cell lines including human cervical 
carcinoma cell line (HeLa) and Human Umbilical 
Vein Endothelial Cell line (HUVEC) were 
purchased from the National Cell Bank, Pasteur 
Institute of Iran. 
Preparation of target plant fraction  
     The A. ascalonicum plant was collected from 
the Zagros Mountains in the north of Dezful city- 
Iran, in September 2016 and confirmed by School 
of Pharmacy, Ahvaz Jundishapur University of 
Medical Sciences, Ahvaz, Iran. For the 
preparation of plant extract, 500g bulbs of A. 
ascalonicum were washed completely with water 
and then mashed properly and after mixing with 
500mL of distilled water, the mixture was soaked 
and stirred using a magnetic stirrer. The 
suspension was filtered through 
filter paper (Whatman No. 1) and the extract was 
mixed with ethyl acetate in 50/50 proportions and 
stirred by a magnetic stirrer for 10 minutes. Then 
the upper layer was separated accurately using 
a separating funnel and centrifuged at 7000 rpm 
for 10 min. The ethyl acetate layer was removed 
and the remaining residue was re-extracted twice 
and the fraction was dried in a rotary evaporator 
(Heidolph-Germany) at 50 
0
C. The separated 
fraction by column chromatography, which 
showed antibacterial activity, was used as an 
active fraction in this study.  According to our 
previous study this fraction could be identified by 
chemical methods such as nuclear magnetic 
resonance (NMR) spectroscopy, infrared 
spectroscopy (IR) and gas chromatography-mass 
spectrometry (GC/MS) [14], and it was a 
flavonoid with C14H18O6 formula [3]. 
Antibacterial susceptibility test 
      Antibacterial activity of flavonoid fraction of 
A. ascalonicum bulbs against both Gram-positive 
and negative bacteria was determined by 
minimum inhibitory concentration (MIC), which 
were determined using an improved E test 
method (AB Biodisk, Solna, Sweden) in order to 
show the antimicrobial and anticancer activity. In 
the improved E test, several AB Bio discs 
impregnated with different dilutions of the 
extracts were used instead of strips. In fact, it was 
a simulated version of the standard E test (15). 
First, the extract was dried by Rotary Evaporator, 
then was double dilutioned in methanol and 
impregnated 10µl from each dilution in each 
blank disc and then, the dry amount in each disc 
was calculated. The ciprofloxacin and gentamicin 
powders were used as positive and DMSO10% as 




negative controls, simultaneously.Six 
concentrations of the extract including          0.18,  
0.37, 0.75, 1.5, 3 and 6 mg/mL were prepared. 
The bacterial suspension vancomycin resistant 
Staphylococcus aureus (PTCC: 29213)           was  
  adjustedto equal the turbidity of 0.5    McFarland     
standards giving a final inoculum of 1.5 X 10
8
 
CFU/mL. They were then subcultured on Mueller 
Hinton agar (MHA) medium and 8 blank discs 
were placed gently on the surface of MHA plates. 
Ten microliters of each concentration of the 
flavonoid fraction of A. ascalonicum plant 
was impregnated on the separate sterile blank 
disc using sterile micropipette and incubated for 
24 hours at 37 
0
C. The test was carried out with 
quadruplicates for each bacterium and the disc 
which did not show inhibition zone was 
considered as MIC (3) and the amount of dried 
extract in this disc and it is MIC was calculated. 
Anticancer susceptibility test 
       The cells were cultured in Dulbecco's 
Modified Eagle Medium (DMEM) (Gibco, 
Gaithersburg, MD) supplemented with 10% fetal 
bovine serum (FBS) (Gibco), penicillin  
(100 IU/mL), streptomycin (100 μg/mL) 
(Bioidea, Iran) and incubated in a humidified 5% 
CO2 atmosphere at 37 
0
C.  When the subcultures 
reached 50% to 80% confluence, they were 
trypsinized to a single cell suspension and 
subcultured in new culture flasks. After the 
subcultures reached more than 80% confluence 
(29 X 10
6
), they were re-trypsinized to a single 
cell suspension and passaged in lower numbers in 
new culture flasks. For investigation of anticancer 
properties of the flavonoid fraction of A. 
ascalonicum, several concentrations of the extract 
(0.18, 0.37, 0.75, 1.5, 3 and 6 mg/mL) were 
prepared. The anticancer effect of flavonoid 
fraction of this plant was evaluated against HeLa 
and HUVEC human cancer cell lines using 3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) method [16]. This study was 
performed in 96-well plates. Cells were cultured 
at a concentration of (5 × 10
5
) cells/well and 
incubated for 48 hours at 37°C in 5% CO2. 
Microscopic observation showed that cell layers 
were suitable in each well. The passaged cells 
were treated with the dilutions of the fraction  
and their effects were examined at different times  
(24-72h). The cells in each well were incubated 
with 10 µL of the MTT solution (5 mg/mL) 
(Sigma-Aldrich Chemical, Germany). Then, 
200μL Dimethylsulfoxide (DMSO) (Sigma) was  
added to dissolve the formazan crystals. The 
amount of purple formazan was determined by 
measuring the optical density (OD) using the 
ELISA reader (BioRad, USA) at 582 nm and the 
cell viability was calculated as the percentage of 
surviving cells after extract treatment. The effects 
of A.ascalonicum were expressed by IC50 values 
(the concentration required for a 50% viability 
inhibition). 
Calculation of Cell Viability 
     The rate of viable cells = Number of Viable 
Cells / Total Cells x 100 . Total cells mean viable 
plus dead cells. 
 
STATISTICAL ANALYSIS 
Statistical analysis of experimental results and 
determination of inhibitory concentration 50% 
(IC50) was performed through SPSS software 
version 16. All data were expressed as means ± 
standard deviation. The statistical significance of 
the difference was determined and was 
considered significant at p < 0.05 
 
RESULTS 
        Antibacterial activity of flavonoid fraction 
of A. Ascalonicum bulbs were evaluated against 
some selected bacteria using MIC method and the 
cytotoxic effect of the extract was determined on 
HeLa and HUVEC cells by the MTT assay. The 
antibacterial inhibitory activity of this flavonoid 
was found against all tested bacteria. The best 
antibacterial effect of the fraction was 
demonstrated in concentration of 1.5 µg/mL 
against the C. diphtheriae. However, in the 
current study, gentamicin resistant P. aeruginosa 
was the most resistant pathogenic bacterium 
(MIC=25 µg/mL) (Figure1). The inhibitory 
effects of flavonoid fraction of this herbal 
medicine on other tested bacteria are mentioned 
in Table 1. According to our data, MTT assay 
showed that this active extract of A. ascalonicum 
had a concentration-dependent anti-proliferative 
activity on HeLa cell lines and there   was      no 
cytotoxic effect       against      HUVEC         cells 
(Table 2 and Table 3). 





A      B 
 
Figure1. Antimicrobial activity of flavonoid fraction of A. ascalonicum against C. diphtheria (A) and Gentamicin resistant P. 
aeruginosa (B) 
 
Table 1. The antibacterial effects of flavonoid fraction of A. ascalonicum, against selected bacteria 
MRSA*4 VRSA*
5 
VREF*3 GRPA*2 TREC*1 E. coli K.pneumoniae S. pyogenes C.diphtheria B.cereus Bacteria 
6.25 6.25 6.25 25 6.25 3.1 6.25 12.5 1.5 3.1 MIC(μg/mL) 
*1: Tobramycin resistant E. coli,  *2: Gentamicin resistant P. aeruginosa 
*3: Vancomycin-resistant Enterococcus faecalis, *4: Methicillin resistant Staphylococcus aureus 
*5: Vancomycin resistant Staphylococcus aureus 
 
 




Amount of OD after 
24h 







HeLa cell line HUVEC 
cell line 
HeLa cell line 
6 0.33 0.14 0.33 0.118 0.32 0.05 
3 0.337 0.161 0.337 0.124 0.331 0.06 
1.5 0.339 0.194 0.337 0.144 0.331 0.07 
0.75 0.341 0.205 0.34 0.148 0.338 0.1 
0.37 0.346 0.280 0.34 0.226 0.339 0.204 
0.18 0.349 0.333 0.349 0.315 0.346 0.274 




     *It contains cancer cells, DMEM culture medium and DMSO solution without extract A. ascalonicum  
  Dulbecco's Modified Eagle's medium (DMEM) Dimethyl sulfoxide (DMSO)     
 
Table 3. Association between concentrations of flavonoid fraction of A. ascalonicum and Mean± SD biological survival rates (OD) 
of cells in different times 
COE: Concentration of extracts 
 
The IC50 values of the A. ascalonicum extract for 
Hela cell was 3 mg/mL but the treatment of 
HUVECs with the A. ascalonicum showed no 
considerable effect. The potential of the 
COE 
mg/ml 














6 40.25±4.11 94.0±4.1 34.0±4.05 94.0±3.9 16.15±4.08 94.0±4.8 
3 48.2±4.0 96±.03.9 36.5±4.25 96.0±4.0 20.1±5.01 94.0±4.1 
1.5 56.3±5.0 97.0±4.2 40.14±5.45 97.0±3.1 22.0±3.65 94.0±3.2 
0.75 60.25±4.12 98.0±3.0 42.56±2.18 97.0±3.0 32.25±3.18 97.0±4.2 
0.37 88.18±2.11 99.0±2.0 63.3±3.07 99.0±2.1 60.02±2.04 98.0±3.0 
0.18 95.18±2.11 100±2.1 88.1±3.06 100±3.5 86.1±3.89 99.0±4.0 
P value 0.015 _        _        _ 




anticancer activity of the fraction to discriminate 
between normal and cancer cells is an important 
paradigm in the design and discovery of 
chemotherapeutic agents. The results of the 
current study demonstrated that HeLa cells were 
more sensitive to the cytotoxic activity        of the  
plant while HUVEC showed no sensitivity to the  
extract. The highest sensitivity of cancer cell lines 
to flavonoid fraction   of A. ascalonicum         was  
presented after 72 hours. Detachment, shrinkage, 
and granulation of cytoplasm were seen in treated 
cells with flavonoid fraction of A. ascalonicum  
(Figure 2). Statistical analysis showed that at 24 
hours incubation time of cell viability from 40% 
(at a concentration of 6 mg/mL) to 16% (after 72  
hours) decreased and the difference was 




           A                                                                         B 
Figure 2.  Microscopic images of Hela cell after 72 h incubation with flavonoid fraction of A. ascalonicum. Detachment and 





Figure 3. Association between concentrations of flavonoid fraction of A. ascalonicum and cell viability rate in different times  
 
DISCUSSION 
         Infectious diseases and cancers are 
the main causes of morbidity-mortality 
worldwide and there is a constant demand for 
new therapies to treat and prevent these life-
threatening diseases. Use of synthetic 
antibacterial and anticancer drugs 
have not succeeded within the broad range 
of clinically relevant bacterial pathogens and cell 
lines, probably because of their adverse side 
effects and antimicrobial resistance [17]. 
Nowadays, the use of herbal medicines has been 
considered for treatment of infectious diseases 
and cancers due to their fewer side effects in 
compression to chemical medicines. The previous 
studies have shown that the various extracts of A. 
ascalonicum have antibacterial activity against 
pathogenic bacteria [3-16]. In the current study, 
the best antibacterial inhibitory effect of 
flavonoid fraction of A. ascalonicum was found 




against C. diphtheria. Furthermore, gentamicin 
resistant P.aeruginosa was the most resistant 
pathogenic bacterium. Amin et al in their study 
have evaluated the effect of the flavonoid fraction 
of A ascalonicum against a number of bacteria 
and showed the best effect of this fraction against  
Bacillus cereus [3]. To the best of the authors’ 
knowledge, there are a few reports detailing the 
antibacterial effects of flavonoid fraction of A. 
ascalonicum bulbs against bacteria. Wang and Ng 
have isolated an antifungal peptide from bulbs of 
A. ascalonicum and showed that this peptide 
inhibited mycelial growth in the fungus Botrytis 
cinerea. However, this isolated antifungal peptide 
did not inhibit Mycosphaerella arachidicola and 
Fusarium oxysporum  [18]. In another study, the 
MICs of the extract of shallot against 
Trichophyton mentagrophytes, Aspergillus niger, 
Aspergillus flavus and Aspergillus fumigatus 
were 0.62, 10, 20 and 20 mg/mL respectively [3].  
The other studies which have been done in this 
field revealed the antibacterial effect of the 
extracts of A. ascalonicum against 
Mycobacterium tuberculosis and Listeria 
monocytogenes. As fraction of Shallot extract 
showed, antimycobacterial activity with a MIC 
value of 500 μg/mL and its essential oils had the 
highest antimicrobial effects against L. 
monocytogenes [19,20,21]. Many studies also 
demonstrated that the family of  Allium possesses 
anticancer activities as shown through their 
capacity to prevent tumor proliferation in vitro 
and in vivo [22]. In spite of extensive 
consumption of A. ascalonicum, reports regarding 
its organic effects are rarely compared to other 
Allium species such as onion and garlic. A. 
ascalonicum is      usually           known      for 
antidermatophytic, anti-angiogenic and Hypocho 
lesterolemic  properties [23,24]. In the current 
study, flavonoid fraction of A. ascalonicum plant 
had a concentration-dependent inhibition activity 
on HeLa cells, but the treatment of HUVECs with 
the A. ascalonicum showed no considerable 
effect. In a study performed by Azadi et al. the in 
vitro effect of chloroformic and aqueous extracts 
of Iranian shallot (Allium hirtifolium) on the 
proliferation of HeLa, L929 (mouse 
fibroblast cell line) and MCF7 (human breast 
adenocarcinoma cell line) cells were investigated. 
Although Hela and MCF-7 cell lines were 
sensitive to Iranian shallot, the cell survival rate 
was almost unchanged in L929 cells.  It means 
that A. hirtifolium did not affect the normal L929 
mouse cells and it only decreased cancer cell 
populations [13].  A.hirtifolium showed growth 
inhibitory effect against MCF-7 and HeLa cells 
with IC50 values of 24 and 20 mg/mL, 
respectively, for 72 h. These results approved the 
data of the present study on the sensitivity of this 
cell line to flavonoid fraction of A.ascalonicum.  
In this study, there is an association between 
concentrations of flavonoid fraction of A. 
ascalonicum and cell viability rate at different 
times. According to data, increase in the 
concentration of A. ascalonicum extract decreases 
the cell viability count. This result confirms the 
reports of previous studies about the dose-
dependent effect of A. ascalonicum extract on the 
inhibition of proliferation of cancer cells [12, 25]. 
In the study conducted by Pandurangan et al., 
anticancer effect of fresh and dry A. ascalonicum 
was assessed against liver cancer cell line HepG2 
by MTT. The result shows that both extracts of 
shallot have anticancer potential (IC50 of 50 
μg/mL) [11]. Finally, isolation of total extract 
components and identification of their 
combinations are recommended for future 
studies. Correspondingly, doing further studies to 
determine the cytotoxicity of other effective 
fraction is recommended.  Moreover, it is hoped 
that through proven different extracts of A. 
ascalonicum, the product could be useful as a 
medicinal plant in one of the pharmaceutical 
forms in future. 
 
CONCLUSION  
       This study highlights promoting increased 
consumption of this plant as a necessary means to 
inhibit or even to cancer therapy. However, 
supplementary studies are essential for 
assessment of the molecular mechanisms of 
anticancer effects of active composites from 
shallot. 
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